Microsoft and Google decline over 1% each while Eli Lilly jumps 4% on strong clinical trial results and sector rotation.
Technology stocks led losses in today’s session, with Microsoft (MSFT) down 1.11% and Alphabet (GOOGL) falling 2.01%. Investors cited concerns over elevated valuations and regulatory pressures as key drivers of the decline.
Healthcare outperformed, with Eli Lilly (LLY) surging 4.05% and Gilead Sciences (GILD) rising 2.62%. Positive clinical trial updates and sustained demand for innovative treatments fueled the sector’s rally.
Consumer cyclicals also struggled, as Tesla (TSLA) dropped 2.37% amid inventory concerns. Nvidia (NVDA) bucked the tech trend, gaining 1.40% on strong AI-driven demand.